全球潛伏性結核傳染病 (LTBI) 檢測市場規模調查和預測:按測試類型、最終用戶和地區分析,2022-2029 年
市場調查報告書
商品編碼
1215393

全球潛伏性結核傳染病 (LTBI) 檢測市場規模調查和預測:按測試類型、最終用戶和地區分析,2022-2029 年

Global Latent Tuberculosis Infection Detection Market Size study & Forecast, by Test Type, by End-User and Regional Analysis, 2022-2029

出版日期: | 出版商: Bizwit Research & Consulting LLP | 英文 | 商品交期: 2-3個工作天內

價格

潛伏性結核感染是一種細菌在體內休眠而不活躍的結核感染。

通過結核菌素皮膚試驗 (TST) 檢測。 其他疾病會增加風險,例如藥物濫用、艾滋病毒和削弱免疫系統的藥物。 結核病檢測需求激增、管理疾病治療的資金增加以及老年人口增加等因素正在推動全球市場增長。

由潛伏性結核感染 (LTBI) 發展為活動性結核病的風險不斷上升正在推動全球市場需求。 據 TBFacts.org 稱,到 2021 年,估計約有 40% 的印度人會感染結核桿菌,其中大多數患有潛伏性結核病,而不是活動性結核病。 同樣,美國疾病控制與預防中心 2021 年的一份報告估計,美國有多達 1300 萬人患有潛伏性結核病感染。 因此,人群中潛伏性結核感染的高患病率正在促進市場增長。 此外,非政府組織和市場參與者開展的提高認識運動,以及政府加大治療潛伏性結核病的力度,在未來幾年創造了多種機會。 然而,缺乏系統的結核病篩查方法、缺乏適當的建議和報銷政策阻礙了整個 2022-2029 年預測期內的市場增長。

全球潛伏性結核感染檢測市場研究中考慮的主要區域是亞太地區、北美、歐洲、拉丁美洲和世界其他地區。 由於對感染早期診斷意識的提高、結核病控制的高額資金以及醫療保健設施的改善,北美在收入方面佔據了市場主導地位。 另一方面,預計亞太地區在預測期內將以最高複合年增長率增長。 新興國家的高感染率、人口增長和有利的政府舉措等因素在預測期內推動了市場增長。

這項研究的目的是揭示近年來各個細分市場和國家/地區的市場規模,並預測未來幾年的市場規模。 本報告旨在捕捉被調查國家行業的定性和定量方面的情況。

它還提供了關鍵方面的詳細信息,例如決定市場未來增長的驅動因素和挑戰。 此外,它還包含供利益相關者投資的微觀市場潛在機會,以及對主要參與者的競爭格局和產品供應的深入分析。

內容

第 1 章執行摘要

  • 市場概況
  • 2019-2029 年全球市場和細分市場的估計和預測
    • 潛伏性結核感染檢測市場:按地區劃分,2019-2029 年
    • 潛伏性結核感染檢測市場:按檢測類型,2019-2029
    • 潛伏性結核感染檢測市場:按最終用戶分類,2019-2029 年
  • 主要趨勢
  • 調查方法
  • 調查先決條件

第 2 章潛伏性結核感染檢測的全球市場定義和範圍

  • 調查的目的
  • 市場定義和範圍
    • 調查範圍
    • 工業發展
  • 調查年份
  • 貨幣兌換率

第 3 章全球潛伏性結核感染檢測市場動態

  • 潛伏性結核感染檢測市場影響分析(2019-2029)
    • 市場驅動力
      • 因潛伏性結核感染 (LTBI) 而發展為活動性結核病的風險增加
      • 結核病檢測需求激增
    • 市場挑戰
      • 缺乏篩查結核病的系統方法
      • 缺乏適當的建議和報銷政策
    • 市場機會
      • 增加非政府組織和市場參與者的宣傳活動
      • 政府增加治療潛伏性結核病的舉措

第 4 章全球潛伏性結核感染檢測市場行業分析

  • 波特 5 力模型
    • 供應商的議價能力
    • 買家的議價能力
    • 新進入者的威脅
    • 替代品的威脅
    • 競爭公司之間的敵對關係
  • 波特 5 力模型的未來方法 (2019-2029)
  • 害蟲分析
    • 政治
    • 經濟的
    • 社交
    • 技術
  • 頂級投資機會
  • 關鍵成功策略
  • 行業專家的展望
  • 分析師的結論和建議

第 5 章風險評估:COVID-19 的影響

  • 評估 COVID-19 對行業的總體影響
  • COVID-19 之前和 COVID-19 之後的市場情景

第 6 章全球潛伏性結核感染檢測市場:按檢測類型

  • 市場概況
  • 全球潛伏性結核感染檢測市場(按測試類型、性能-潛力分析)
  • 2019-2029 年全球潛伏性結核感染檢測市場按測試類型的估計和預測
  • 潛伏性結核感染檢測市場,細分分析
    • 結核菌素皮膚反應試驗
    • 干擾素γ釋放試驗

第 7 章:潛伏性結核感染檢測的全球市場:最終用戶

  • 市場概況
  • 全球潛伏性結核感染檢測市場:按最終用戶分類,性能潛力分析
  • 最終用戶對潛伏性結核感染檢測的全球市場估計和預測:2019-2029
  • 潛伏性結核感染檢測市場,細分分析
    • 診斷實驗室
    • 醫院/診所
    • 學術和研究機構

第 8 章全球潛伏性結核感染檢測市場:區域分析

  • 潛伏性結核感染檢測市場的區域市場概況
  • 北美
    • 美國
      • 按測試類型估算和預測,2019-2029 年
      • 2019-2029 年最終用戶的估計和預測
    • 加拿大
  • 歐洲潛伏性結核感染檢測市場概況
    • 英國
    • 德國
    • 法國
    • 西班牙
    • 意大利
    • 其他歐洲地區
  • 亞太地區潛伏性結核感染檢測市場概況
    • 中國
    • 印度
    • 日本
    • 澳大利亞
    • 韓國
    • 其他亞太地區
  • 拉丁美洲潛伏性結核感染檢測市場概況
    • 巴西
    • 墨西哥
    • 其他拉丁美洲地區
  • 世界其他地方

第 9 章衝突信息

  • 頂級市場策略
  • 公司簡介
    • QIAGEN N.V.
      • 主要信息
      • 概覽
      • 財務信息(取決於數據可用性)
      • 產品概述
      • 近期趨勢
    • Oxford Immunotec Inc.
    • F. Hoffmann-La Roche Ltd.
    • Sanofi S.A.
    • Abbott Laboratories
    • bioMerieux SA
    • Becton, Dickinson, and Company
    • Endo International plc
    • PerkinElmer, Inc.
    • Bruker Corporation

第 10 章研究過程

  • 研究過程
    • 數據挖掘
    • 分析
    • 市場評估
    • 驗證
    • 出版
  • 調查屬性
  • 調查先決條件

Global Latent Tuberculosis Infection Detection Market is valued at approximately USD XX billion in 2021 and is anticipated to grow with a healthy growth rate of more than XX% over the forecast period 2022-2029. Latent Tuberculosis Infection (LTBI) is a variety of TB infection in which bacteria remains inactive specifically bacteria that exists in the sleeping state inside the individual's body. The detection of this infection is identified by the tuberculin skin test (TST). The risk is increased by other diseases including drug abuse, HIV, or medications that weakens the immune system. Factors such as surging demand for tuberculosis testing, growing funding to manage disease treatment, and increasing geriatric population are driving the market growth globally.

The rising risk of developing active TB from latent tuberculosis infection (LTBI) is propelling the demand for market across the globe. According to TBFacts.org, in 2021, about 40% of Indians are estimated to be infected with the TB bacteria, with the great majority having latent TB instead of active TB disease. Likewise, according to the Centers for Disease Control and Prevention report 2021, it was estimated that up to 13 million people in the United States suffered from latent TB infection. Therefore, the high prevalence rate of latent tuberculosis infection among the population is augmenting the market growth. Furthermore, growing awareness campaigns conducted by non-government bodies and market players, as well as a rising number of government initiatives to treat LTBI are leveraging multiple opportunities in the foreseen years. However, the lack of a systematic approach to screening tuberculosis and the unavailability of proper recommendations and reimbursement policies are hindering market growth throughout the forecast period of 2022-2029.

The key regions considered for the Global Latent Tuberculosis Infection Detection Market study include Asia Pacific, North America, Europe, Latin America, and the Rest of the World. North America dominated the market in terms of revenue, owing to the growing awareness about early diagnosis of infection, high funding for tuberculosis management, and improvement of healthcare facilities. Whereas, Asia Pacific is expected to grow at the highest CAGR during the forecast period. Factors such as high infection rates in developing countries, increasing population, as well as government favorable initiatives are burgeoning the market growth in the forecasting years.

Major market players included in this report are:

QIAGEN N.V.

Oxford Immunotec Inc.

F. Hoffmann-La Roche Ltd.

Sanofi S.A.

Abbott Laboratories

bioMerieux SA

Becton, Dickinson, and Company

Endo International plc

PerkinElmer, Inc.

Bruker Corporation

Recent Developments in the Market:

  • In February 2022, QIAGEN N.V. announced that the company received approval for its QuantiFERON tuberculosis testing solution in China. With this strategic initiative company aims to boost its market share across the region.

Global Latent Tuberculosis Infection Detection Market Report Scope:

Historical Data: 2019-2020-2021

Base Year for Estimation: 2021

Forecast period: 2022-2029

Report Coverage: Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends

Segments Covered: Test Type, End-User, Region

Regional Scope: North America; Europe; Asia Pacific; Latin America; Rest of the World

Customization Scope: Free report customization (equivalent up to 8 analyst's working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define the market sizes of different segments & countries in recent years and to forecast the values for the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within the countries involved in the study.

The report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with a detailed analysis of the competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Test Type:

Tuberculin Skin Test

Interferon Gamma Release Assays

By End User:

Diagnostic Laboratories

Hospitals/Clinics

Academic & Research Institutions

By Region:

North America

U.S.

Canada

Europe

UK

Germany

France

Spain

Italy

ROE

Asia Pacific

China

India

Japan

Australia

South Korea

RoAPAC

Latin America

Brazil

Mexico

ROLA

Rest of the World

Table of Contents

Chapter 1. Executive Summary

  • 1.1. Market Snapshot
  • 1.2. Global & Segmental Market Estimates & Forecasts, 2019-2029 (USD Billion)
    • 1.2.1. Latent Tuberculosis Infection Detection Market, by Region, 2019-2029 (USD Billion)
    • 1.2.2. Latent Tuberculosis Infection Detection Market, by Test Type, 2019-2029 (USD Billion)
    • 1.2.3. Latent Tuberculosis Infection Detection Market, by End-User, 2019-2029 (USD Billion)
  • 1.3. Key Trends
  • 1.4. Estimation Methodology
  • 1.5. Research Assumption

Chapter 2. Global Latent Tuberculosis Infection Detection Market Definition and Scope

  • 2.1. Objective of the Study
  • 2.2. Market Definition & Scope
    • 2.2.1. Scope of the Study
    • 2.2.2. Industry Evolution
  • 2.3. Years Considered for the Study
  • 2.4. Currency Conversion Rates

Chapter 3. Global Latent Tuberculosis Infection Detection Market Dynamics

  • 3.1. Latent Tuberculosis Infection Detection Market Impact Analysis (2019-2029)
    • 3.1.1. Market Drivers
      • 3.1.1.1. Rising risk of developing active TB from latent tuberculosis infection (LTBI)
      • 3.1.1.2. Surging demand for tuberculosis testing
    • 3.1.2. Market Challenges
      • 3.1.2.1. Lack of a systematic approach to screening tuberculosis
      • 3.1.2.2. Unavailability of proper recommendations and reimbursement policies
    • 3.1.3. Market Opportunities
      • 3.1.3.1. Growing awareness campaigns conducted by non-government bodies and market players
      • 3.1.3.2. Rising number of government initiatives to treat LTBI

Chapter 4. Global Latent Tuberculosis Infection Detection Market Industry Analysis

  • 4.1. Porter's 5 Force Model
    • 4.1.1. Bargaining Power of Suppliers
    • 4.1.2. Bargaining Power of Buyers
    • 4.1.3. Threat of New Entrants
    • 4.1.4. Threat of Substitutes
    • 4.1.5. Competitive Rivalry
  • 4.2. Futuristic Approach to Porter's 5 Force Model (2019-2029)
  • 4.3. PEST Analysis
    • 4.3.1. Political
    • 4.3.2. Economical
    • 4.3.3. Social
    • 4.3.4. Technological
  • 4.4. Top investment opportunity
  • 4.5. Top winning strategies
  • 4.6. Industry Experts Prospective
  • 4.7. Analyst Recommendation & Conclusion

Chapter 5. Risk Assessment: COVID-19 Impact

  • 5.1. Assessment of the overall impact of COVID-19 on the industry
  • 5.2. Pre COVID-19 and post COVID-19 Market scenario

Chapter 6. Global Latent Tuberculosis Infection Detection Market, by Test Type

  • 6.1. Market Snapshot
  • 6.2. Global Latent Tuberculosis Infection Detection Market by Test Type, Performance - Potential Analysis
  • 6.3. Global Latent Tuberculosis Infection Detection Market Estimates & Forecasts by Test Type 2019-2029 (USD Billion)
  • 6.4. Latent Tuberculosis Infection Detection Market, Sub Segment Analysis
    • 6.4.1. Tuberculin Skin Test
    • 6.4.2. Interferon Gamma Release Assays

Chapter 7. Global Latent Tuberculosis Infection Detection Market, by End-User

  • 7.1. Market Snapshot
  • 7.2. Global Latent Tuberculosis Infection Detection Market by End-User, Performance - Potential Analysis
  • 7.3. Global Latent Tuberculosis Infection Detection Market Estimates & Forecasts by End-User 2019-2029 (USD Billion)
  • 7.4. Latent Tuberculosis Infection Detection Market, Sub Segment Analysis
    • 7.4.1. Diagnostic Laboratories
    • 7.4.2. Hospitals/Clinics
    • 7.4.3. Academic & Research Institutions

Chapter 8. Global Latent Tuberculosis Infection Detection Market, Regional Analysis

  • 8.1. Latent Tuberculosis Infection Detection Market, Regional Market Snapshot
  • 8.2. North America Latent Tuberculosis Infection Detection Market
    • 8.2.1. U.S. Latent Tuberculosis Infection Detection Market
      • 8.2.1.1. Test Type breakdown estimates & forecasts, 2019-2029
      • 8.2.1.2. End-User breakdown estimates & forecasts, 2019-2029
    • 8.2.2. Canada Latent Tuberculosis Infection Detection Market
  • 8.3. Europe Latent Tuberculosis Infection Detection Market Snapshot
    • 8.3.1. U.K. Latent Tuberculosis Infection Detection Market
    • 8.3.2. Germany Latent Tuberculosis Infection Detection Market
    • 8.3.3. France Latent Tuberculosis Infection Detection Market
    • 8.3.4. Spain Latent Tuberculosis Infection Detection Market
    • 8.3.5. Italy Latent Tuberculosis Infection Detection Market
    • 8.3.6. Rest of Europe Latent Tuberculosis Infection Detection Market
  • 8.4. Asia-Pacific Latent Tuberculosis Infection Detection Market Snapshot
    • 8.4.1. China Latent Tuberculosis Infection Detection Market
    • 8.4.2. India Latent Tuberculosis Infection Detection Market
    • 8.4.3. Japan Latent Tuberculosis Infection Detection Market
    • 8.4.4. Australia Latent Tuberculosis Infection Detection Market
    • 8.4.5. South Korea Latent Tuberculosis Infection Detection Market
    • 8.4.6. Rest of Asia Pacific Latent Tuberculosis Infection Detection Market
  • 8.5. Latin America Latent Tuberculosis Infection Detection Market Snapshot
    • 8.5.1. Brazil Latent Tuberculosis Infection Detection Market
    • 8.5.2. Mexico Latent Tuberculosis Infection Detection Market
    • 8.5.3. Rest of Latin America Latent Tuberculosis Infection Detection Market
  • 8.6. Rest of The World Latent Tuberculosis Infection Detection Market

Chapter 9. Competitive Intelligence

  • 9.1. Top Market Strategies
  • 9.2. Company Profiles
    • 9.2.1. QIAGEN N.V.
      • 9.2.1.1. Key Information
      • 9.2.1.2. Overview
      • 9.2.1.3. Financial (Subject to Data Availability)
      • 9.2.1.4. Product Summary
      • 9.2.1.5. Recent Developments
    • 9.2.2. Oxford Immunotec Inc.
    • 9.2.3. F. Hoffmann-La Roche Ltd.
    • 9.2.4. Sanofi S.A.
    • 9.2.5. Abbott Laboratories
    • 9.2.6. bioMerieux SA
    • 9.2.7. Becton, Dickinson, and Company
    • 9.2.8. Endo International plc
    • 9.2.9. PerkinElmer, Inc.
    • 9.2.10. Bruker Corporation

Chapter 10. Research Process

  • 10.1. Research Process
    • 10.1.1. Data Mining
    • 10.1.2. Analysis
    • 10.1.3. Market Estimation
    • 10.1.4. Validation
    • 10.1.5. Publishing
  • 10.2. Research Attributes
  • 10.3. Research Assumption

LIST OF TABLES

  • TABLE 1. Global Latent Tuberculosis Infection Detection Market, report scope
  • TABLE 2. Global Latent Tuberculosis Infection Detection Market estimates & forecasts by Region 2019-2029 (USD Billion)
  • TABLE 3. Global Latent Tuberculosis Infection Detection Market estimates & forecasts by Test Type 2019-2029 (USD Billion)
  • TABLE 4. Global Latent Tuberculosis Infection Detection Market estimates & forecasts by End-User 2019-2029 (USD Billion)
  • TABLE 5. Global Latent Tuberculosis Infection Detection Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 6. Global Latent Tuberculosis Infection Detection Market by region, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 7. Global Latent Tuberculosis Infection Detection Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 8. Global Latent Tuberculosis Infection Detection Market by region, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 9. Global Latent Tuberculosis Infection Detection Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 10. Global Latent Tuberculosis Infection Detection Market by region, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 11. Global Latent Tuberculosis Infection Detection Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 12. Global Latent Tuberculosis Infection Detection Market by region, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 13. Global Latent Tuberculosis Infection Detection Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 14. Global Latent Tuberculosis Infection Detection Market by region, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 15. U.S. Latent Tuberculosis Infection Detection Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 16. U.S. Latent Tuberculosis Infection Detection Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 17. U.S. Latent Tuberculosis Infection Detection Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 18. Canada Latent Tuberculosis Infection Detection Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 19. Canada Latent Tuberculosis Infection Detection Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 20. Canada Latent Tuberculosis Infection Detection Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 21. UK Latent Tuberculosis Infection Detection Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 22. UK Latent Tuberculosis Infection Detection Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 23. UK Latent Tuberculosis Infection Detection Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 24. Germany Latent Tuberculosis Infection Detection Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 25. Germany Latent Tuberculosis Infection Detection Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 26. Germany Latent Tuberculosis Infection Detection Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 27. France Latent Tuberculosis Infection Detection Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 28. France Latent Tuberculosis Infection Detection Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 29. France Latent Tuberculosis Infection Detection Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 30. Italy Latent Tuberculosis Infection Detection Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 31. Italy Latent Tuberculosis Infection Detection Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 32. Italy Latent Tuberculosis Infection Detection Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 33. Spain Latent Tuberculosis Infection Detection Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 34. Spain Latent Tuberculosis Infection Detection Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 35. Spain Latent Tuberculosis Infection Detection Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 36. RoE Latent Tuberculosis Infection Detection Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 37. RoE Latent Tuberculosis Infection Detection Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 38. RoE Latent Tuberculosis Infection Detection Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 39. China Latent Tuberculosis Infection Detection Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 40. China Latent Tuberculosis Infection Detection Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 41. China Latent Tuberculosis Infection Detection Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 42. India Latent Tuberculosis Infection Detection Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 43. India Latent Tuberculosis Infection Detection Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 44. India Latent Tuberculosis Infection Detection Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 45. Japan Latent Tuberculosis Infection Detection Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 46. Japan Latent Tuberculosis Infection Detection Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 47. Japan Latent Tuberculosis Infection Detection Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 48. South Korea Latent Tuberculosis Infection Detection Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 49. South Korea Latent Tuberculosis Infection Detection Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 50. South Korea Latent Tuberculosis Infection Detection Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 51. Australia Latent Tuberculosis Infection Detection Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 52. Australia Latent Tuberculosis Infection Detection Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 53. Australia Latent Tuberculosis Infection Detection Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 54. RoAPAC Latent Tuberculosis Infection Detection Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 55. RoAPAC Latent Tuberculosis Infection Detection Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 56. RoAPAC Latent Tuberculosis Infection Detection Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 57. Brazil Latent Tuberculosis Infection Detection Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 58. Brazil Latent Tuberculosis Infection Detection Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 59. Brazil Latent Tuberculosis Infection Detection Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 60. Mexico Latent Tuberculosis Infection Detection Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 61. Mexico Latent Tuberculosis Infection Detection Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 62. Mexico Latent Tuberculosis Infection Detection Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 63. RoLA Latent Tuberculosis Infection Detection Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 64. RoLA Latent Tuberculosis Infection Detection Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 65. RoLA Latent Tuberculosis Infection Detection Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 66. Row Latent Tuberculosis Infection Detection Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 67. Row Latent Tuberculosis Infection Detection Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 68. Row Latent Tuberculosis Infection Detection Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 69. List of secondary sources, used in the study of global Latent Tuberculosis Infection Detection Market
  • TABLE 70. List of primary sources, used in the study of global Latent Tuberculosis Infection Detection Market
  • TABLE 71. Years considered for the study
  • TABLE 72. Exchange rates considered

List of tables and figures and dummy in nature, final lists may vary in the final deliverable

LIST OF FIGURES

List of figures

  • FIG 1. Global Latent Tuberculosis Infection Detection Market, research methodology
  • FIG 2. Global Latent Tuberculosis Infection Detection Market, Market estimation techniques
  • FIG 3. Global Market size estimates & forecast methods
  • FIG 4. Global Latent Tuberculosis Infection Detection Market, key trends 2021
  • FIG 5. Global Latent Tuberculosis Infection Detection Market, growth prospects 2022-2029
  • FIG 6. Global Latent Tuberculosis Infection Detection Market, porters 5 force model
  • FIG 7. Global Latent Tuberculosis Infection Detection Market, pest analysis
  • FIG 8. Global Latent Tuberculosis Infection Detection Market, value chain analysis
  • FIG 9. Global Latent Tuberculosis Infection Detection Market by segment, 2019 & 2029 (USD Billion)
  • FIG 10. Global Latent Tuberculosis Infection Detection Market by segment, 2019 & 2029 (USD Billion)
  • FIG 11. Global Latent Tuberculosis Infection Detection Market by segment, 2019 & 2029 (USD Billion)
  • FIG 12. Global Latent Tuberculosis Infection Detection Market by segment, 2019 & 2029 (USD Billion)
  • FIG 13. Global Latent Tuberculosis Infection Detection Market by segment, 2019 & 2029 (USD Billion)
  • FIG 14. Global Latent Tuberculosis Infection Detection Market, regional snapshot 2019 & 2029
  • FIG 15. North America Latent Tuberculosis Infection Detection Market 2019 & 2029 (USD Billion)
  • FIG 16. Europe Latent Tuberculosis Infection Detection Market 2019 & 2029 (USD Billion)
  • FIG 17. Asia Pacific Latent Tuberculosis Infection Detection Market 2019 & 2029 (USD Billion)
  • FIG 18. Latin America Latent Tuberculosis Infection Detection Market 2019 & 2029 (USD Billion)
  • FIG 19. Global Latent Tuberculosis Infection Detection Market, company Market share analysis (2021)

List of tables and figures and dummy in nature, final lists may vary in the final deliverable